Fremgangsmåde til fremstilling af et terapeutisk middel til regenereringen af oligodendrocytter
With the method of preparing a therapeutic agent for the treatment of multiple sclerosis, wherein human beta nerve growth factor (NGF) is brought into a pharmaceutically acceptable formulation for administering in a dose between 0.05 mu g and 5 mu g/kg body weight in 5 to 10 injections at an interva...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | dan |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | With the method of preparing a therapeutic agent for the treatment of multiple sclerosis, wherein human beta nerve growth factor (NGF) is brought into a pharmaceutically acceptable formulation for administering in a dose between 0.05 mu g and 5 mu g/kg body weight in 5 to 10 injections at an interval of 7 to 21 days, the regeneration of oligodendrocytes, especially for the treatment of multiple sclerosis, is improved and remyelination is accelerated. |
|---|